Incyte Corporation (BIT:1INCY)
73.26
+7.16 (10.83%)
At close: Aug 14, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
JAKAFI | 2.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
JAKAFI Growth | 14.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
JAKAVI Product Royalty | 418.84M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
JAKAVI Product Royalty Growth | 10.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Milestone and Contract | 43.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Milestone and Contract Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
ICLUSIG | 114.32M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
ICLUSIG Growth | 6.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
OLUMIANT Product Royalty | 135.57M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
OLUMIANT Product Royalty Growth | 4.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PEMAZYRE | 81.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PEMAZYRE Growth | 8.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
TABRECTA Product Royalty | 22.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
TABRECTA Product Royalty Growth | 30.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
OPZELURA | 508.29M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
OPZELURA Growth | 42.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MINJUVI | 119.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MINJUVI Growth | 72.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Product Royalty | 2.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Product Royalty Growth | 25.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
ZYNYZ | 3.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
ZYNYZ Growth | 678.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|